The DOI matches its Crossref record; 72 of the 72 references it cites were found in a registry or an index.
Definition and description of schizophrenia in the DSM-5
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. (2013) · Encyclopedia of Social Work · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,519
Diagnostic and Statistical Manual of Mental Disorders (DSM-IV)
Hu, R. J. (2003) · Encyclopedia of the Neurological Sciences · doi:10.1016/b0-12-226870-9/01070-4 · Cited by 9,117
Insel, T., Cuthbert, B., Garvey, M., Heinssen, R., Pine, D. S., Quinn, K., Sanislow, C., & Wang, P. (2010) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2010.09091379 · Cited by 7,067
Diagnostic and Statistical Manual of Mental Disorders ( DSM ‐ IV ‐ TR )
Segal, D. L. (2010) · The Corsini Encyclopedia of Psychology · doi:10.1002/9780470479216.corpsy0271 · Cited by 4,666
Dementia Praecox or the Group of Schizophrenias
(1951) · Journal of the American Medical Association · doi:10.1001/jama.1951.02920270079043 · Cited by 4,407
Dementia Praecox and Paraphrenia.
(1972) · Annals of Internal Medicine · doi:10.7326/0003-4819-76-6-1058_8 · Cited by 2,901
Remission in Schizophrenia: Proposed Criteria and Rationale for Consensus
Andreasen, N. C., Carpenter, W. T., Kane, J. M., Lasser, R. A., Marder, S. R., & Weinberger, D. R. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.3.441 · Cited by 2,343
Self-citationEstablishment of Diagnostic Validity in Psychiatric Illness: Its Application to Schizophrenia
ROBINS, E., & GUZE, S. B. (1970) · American Journal of Psychiatry · doi:10.1176/ajp.126.7.983 · Cited by 2,243 · cited 1×
“Its validity (Robins and Guze, 1970; Kendell and Jablensky, 2003) is supported by a range of antecedent (familial aggregation, environmental risk factors), and predictive (diagnostic stability, course of illness, treatment response) validators (Bromet et al., 2011; Korver-Nieberg et al., 2011),…”
BackgroundDiagnostic and Statistical Manual of Mental Disorders (DSM-III-R)
Spitzer, R. L., & Williams, J. (1987) · Cited by 1,823
Insel, T. R. (2010) · Nature · doi:10.1038/nature09552 · Cited by 1,783
Cited by
Maternal immune activation and abnormal brain development across CNS disorders
Knuesel, I., Chicha, L., Britschgi, M., Schobel, S. A., Bodmer, M., Hellings, J. A., Toovey, S., & Prinssen, E. P. (2014) · Nature Reviews Neurology · doi:10.1038/nrneurol.2014.187 · Cited by 880
Solmi, M., Seitidis, G., Mavridis, D., Correll, C. U., Dragioti, E., Guimond, S., Tuominen, L., Dargél, A., Carvalho, A. F., Fornaro, M., et al. (2023) · Molecular Psychiatry · doi:10.1038/s41380-023-02138-4 · Cited by 570
Altering the course of schizophrenia: progress and perspectives
Millan, M. J., Andrieux, A., Bartzokis, G., Cadenhead, K., Dazzan, P., Fusar-Poli, P., Gallinat, J., Giedd, J., Grayson, D. R., Heinrichs, M., et al. (2016) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.28 · Cited by 516
Self-citationMillan, M. J., Fone, K., Steckler, T., & Horan, W. P. (2014) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2014.03.008 · Cited by 347
New Targets for Schizophrenia Treatment beyond the Dopamine Hypothesis
Yang, A., & Tsai, S.-J. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18081689 · Cited by 282
Emotional Dysregulation in Children and Adolescents With Psychiatric Disorders. A Narrative Review
Paulus, F. W., Ohmann, S., Möhler, E., Plener, P., & Popow, C. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.628252 · Cited by 280
Singh, T., Walters, J. T. R., Johnstone, M., Curtis, D., Suvisaari, J., Torniainen, M., Rees, E., Iyegbe, C., Blackwood, D., McIntosh, A. M., et al. (2017) · Nature Genetics · doi:10.1038/ng.3903 · Cited by 231
Self-citationPrognosis of Brief Psychotic Episodes: A Meta-analysis
Fusar-Poli, P., Cappucciati, M., Bonoldi, I., Hui, L. M. C., Rutigliano, G., Stahl, D. R., Borgwardt, S., Politi, P., Mishara, A. L., Lawrie, S. M., et al. (2016) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2015.2313 · Cited by 151
Self-citationOxytocin and vasopressin: signalling, behavioural modulation and potential therapeutic effects
Rae, M., Lemos Duarte, M., Gomes, I., Camarini, R., & Devi, L. A. (2022) · British Journal of Pharmacology · doi:10.1111/bph.15481 · Cited by 72
Voss, M., Chambon, V., Wenke, D., Kühn, S., & Haggard, P. (2017) · Brain · doi:10.1093/brain/awx136 · Cited by 68
Aligning physiology with psychology: Translational neuroscience in neuropsychiatric drug discovery
McArthur, R. A. (2017) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2017.02.004 · Cited by 42
Rahimi, S., Sayad, A., Moslemi, E., Ghafouri-Fard, S., & Taheri, M. (2017) · Metabolic Brain Disease · doi:10.1007/s11011-017-0043-z · Cited by 24
Mahfoud, D., Hallit, S., Haddad, C., Fekih-Romdhane, F., & Haddad, G. (2023) · BMC Psychiatry · doi:10.1186/s12888-023-04940-4 · Cited by 12
Sudden unexplained death in schizophrenia patients: An autopsy-based comparative study from China
Wang, S., He, M., Andersen, J., Lin, Y., Zhang, M., Liu, Z., & Li, L. (2023) · Asian Journal of Psychiatry · doi:10.1016/j.ajp.2022.103314 · Cited by 11
Li, L., Du, F., Liu, X., Song, M., Grosso, G., Battino, M., Boesch, C., Li, H., & Liu, X. (2025) · Foods · doi:10.3390/foods14101773 · Cited by 8
“Schizophrenia (SZ) is defined as a chronic and severe psychiatric disorder characterized by cognitive decline and physiological and emotional reduction [1].”
Hahne, I., Zierhut, M., Bergmann, N., Hahn, E., Ta, T. M. T., Calvano, C., Bajbouj, M., & Böge, K. (2026) · Schizophrenia Bulletin · doi:10.1093/schbul/sbae198 · Cited by 4
Metadata
- Authors
- Tandon, R., Gaebel, W., Barch, D. M., Bustillo, J., Gur, R. E., Heckers, S., Malaspina, D., Owen, M. J., Schultz, S., Tsuang, M., Van Os, J., & Carpenter, W.
- Venue
- Schizophrenia Research
- Publisher
- Elsevier BV
- Published
- 2013-10
- Volume
- 150
- Issue
- 1
- Pages
- 3-10
- ISSN
- 0920-9964 (ISSN-L)
- OpenAlex
- W2132665267
- Cited by
- 807
- References
- 72
- FWCI
- 32.96
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.